Table 1.
Detailed number of procedures performed and patients treated on March-April/January-April 2018, 2019, 2020 and % variation calculated between years.
| 2018 Mar–Apr/ Jan–Apr | 2019 Mar–Apr/ Jan–Apr | 2020 Mar–Apr/ Jan–Apr | Variation % 2020−2018 | Variation % 2020−2019 | |
|---|---|---|---|---|---|
| Therapeutic Plasma Exchange | |||||
| Proc. n. | 175/348 | 198/409 | 111/313 | −15 % *** | −13 % *** |
| Pt. n. | 41/53 | 46/59 | 25/51 | −28 % ** | −29 % ** |
| Extracorporeal Photochemotherapy/Photopheresis | |||||
| Proc. n. | 72/134 | 38/84 | 18/61 | −24 % ** | −16 % |
| Pt. n. | 19/21 | 11/16 | 9/12 | −15 % | +6 % |
| Immunoadsorption | |||||
| Proc. n. | 15/27 | 19/25 | 0/5 | −56 % * | −76 % ** |
| Pt. n. | 1/1 | 2/3 | 0/1 | −100 % | −67 % |
| Cascade Filtration | |||||
| Proc. n. | 3/8 | 1/8 | 0/2 | −38 % | −13 % |
| Pt. n. | 1/1 | 1/1 | 0/1 | −100 % | −100 % |
| Red Blood Cell Exchange | |||||
| Proc. n. | 14/27 | 20/33 | 9/27 | −19 % | −27 % * |
| Pt. n. | 8/10 | 14/16 | 7/11 | −16 % | −24 % |
| Adsorptive Cytapheresis | |||||
| Proc. n. | 20/36 | 30/43 | 2/26 | −48 % *** | −62 % *** |
| Pt. n. | 7/10 | 7/8 | 2/6 | −37 % | −54 % |
| Cytoreductive Leukapheresis | |||||
| Proc. n. | 5/8 | 1/3 | 0/1 | −63 % | −33 % |
| Pt. n. | 2/3 | 1/2 | 0/1 | −67 % | −50 % |
| Lipoprotein Apheresis | |||||
| Proc. n. | 28/49 | 35/73 | 26/55 | −10 % | −1 % |
| Pt. n. | 6/7 | 7/7 | 6/6 | +14 % | 0 % |
| Peripheral Blood Stem Cell Collection (autologous) | |||||
| Proc. n. | 12/34 | 19/37 | 17/36 | +12 % | −4 % |
| Pt. n. | 11/27 | 14/29 | 15/30 | +9 % | +2 % |
| Peripheral Blood Stem Cell Collection (allogeneic) | |||||
| Proc. n. | 2/2 | 4/4 | 0/1 | −100 % | −100 % |
| Pt. n. | 2/2 | 3/3 | 0/1 | −100 % | −100 % |
Abbreviations: Proc. n.: procedures number; Pt. n.: patients number. Significance p value * <0,5, **<001, ***<0,001.